METHOD FOR TREATING CANCER USING DUAL ANTAGONISTS OF CXCR1 AND CXCR2

• 收藏
• 分享

专利权人:

Syntrix Biosystems; Inc.

发明人:

John A. Zebala,Dean Y. Maeda,Aaron D. Schuler

申请号：

US16017836

公开号：

US20180296580A1

申请日:

2018.06.25

申请国别(地区):

US

年份:

2018

代理人:

摘要：

What is described is a method for treating cancer in a patient in need of such treatment through the use of a dual CXCR1/2 antagonist by administering a therapeutically effective amount of a dual CXCR1/2 antagonist, or pharmaceutical compositions thereof, either alone as monotherapy, or in combination with at least one other anticancer therapy.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/